Posted by Michael Wonder on 15 Feb 2021
Post-market review of medicines for smoking cessation – stakeholder forum outcome
15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on Thursday 3 December 2020.
A summary of the stakeholder forum is now available.
Consumers, clinicians and peak bodies who have an interest in smoking cessation, and pharmaceutical sponsors who have a current PBS medicine listing for a smoking cessation therapy, were invited to participate in the forum.
The stakeholder forum consisted of presentations from the department and reference group, 11 multiple choice questions that participants answered in a live poll, a live question and answer session, and a survey that participants responded to after the forum.
